Dr. Masri and Dr. C. Michael Gibson discuss: Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis from ATTRibute-CM October 1, 2025 Uncategorized Sponsored by BridgeBio Article Navigation Dr. Lakdawala, Dr. Januzzi and Dr. C. Michael Gibson discuss the findings were presented at HFSA from the phase 2a clinical trial of danicamtiv in patients with genetic DCM Dr. Danielle Belardo and Dr. C. Michael Gisbon discuss: The Target is the Plaque: Stabilization, Regression, and the Role of Imaging and AI in Modern CAD Management